MCID: LCN001
MIFTS: 37

Lice Infestation

Categories: Infectious diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Lice Infestation

MalaCards integrated aliases for Lice Infestation:

Name: Lice Infestation 11 14 75 33
Pediculosis 11 75 33
Louse Infestation 11 33
Mixed Pediculosis 11 71
Lice Infestations 43 71
Pediculosis and Phthirus Infestation 11
Pediculosis and Phthirus Infections 11
Pediculosis and Phthirus Infection 11
Mixed Pediculosis Infestation 11
Infestation by Pediculus 11
Infestation by Anoplura 71
Pediculus Infestation 33
Pediculosis + Lice 11
Lice Nos 33

Classifications:



External Ids:

Disease Ontology 11 DOID:5502
ICD9CM 34 132.9
MeSH 43 D010373
NCIt 49 C128401
SNOMED-CT 68 74949007
UMLS 71 C0030756 C0277348 C0277351

Summaries for Lice Infestation

Disease Ontology: 11 A parasitic ectoparasitic infectious disease that involves infestation of lice, which are blood-feeding ectoparasitic insects of the order Phthiraptera.

MalaCards based summary: Lice Infestation, also known as pediculosis, is related to pediculus humanus corporis infestation and pthirus pubis infestation. An important gene associated with Lice Infestation is KDR (Kinase Insert Domain Receptor). The drugs Pharmaceutical Solutions and Ethanol have been mentioned in the context of this disorder. Affiliated tissues include skin, eye and liver.

Wikipedia: 75 Pediculosis is an infestation of lice from the sub-order Anoplura, family Pediculidae. Accordingly, the... more...

Related Diseases for Lice Infestation

Diseases related to Lice Infestation via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 96)
# Related Disease Score Top Affiliating Genes
1 pediculus humanus corporis infestation 32.2 MT-CYB MT-CO1
2 pthirus pubis infestation 31.4 MIR4804 MIR4774 DTX2
3 pediculus humanus capitis infestation 31.2 MT-CYB MT-CO1 LINC01554 KDR COX18 BNIP3L
4 myiasis 31.1 MT-CYB MT-CO1
5 trench fever 30.3 MT-CYB MT-CO1 COX18
6 tick infestation 30.2 MT-CYB MT-CO1 AKIRIN2
7 parasitic ectoparasitic infectious disease 30.1 MT-CYB MT-CO1 KDR AKIRIN2
8 deficiency anemia 10.4
9 oesophagostomiasis 10.3 MT-CYB MT-CO1
10 coenurosis 10.3 MT-CYB MT-CO1
11 dracunculiasis 10.3 MT-CYB MT-CO1
12 parathyroid oncocytic adenoma 10.3 MT-CYB MT-CO1
13 phlebotomus fever 10.3 MT-CYB MT-CO1
14 sparganosis 10.3 MT-CYB MT-CO1
15 iron metabolism disease 10.3
16 angiostrongyliasis 10.2 MT-CYB MT-CO1
17 mitochondrial myopathy, infantile, transient 10.2 MT-CYB MT-CO1
18 tungiasis 10.2
19 eosinophilic meningitis 10.2 MT-CYB MT-CO1
20 familial colorectal cancer 10.2 MT-CYB MT-CO1
21 tick paralysis 10.2 MT-CO1 AKIRIN2
22 eastern equine encephalitis 10.2 MT-CYB MT-CO1
23 endemic typhus 10.2 MT-CYB MT-CO1
24 exanthem 10.2
25 bacillary angiomatosis 10.2 MT-CYB COX18
26 bartonellosis 10.2 MT-CYB MT-CO1
27 parasitic protozoa infectious disease 10.2 MT-CYB MT-CO1 KDR
28 iron deficiency anemia 10.2
29 scabies 10.2
30 blepharitis 10.2
31 articulation disorder 10.2 MT-CYB MT-CO1 LINC01554
32 stuttering 10.1 MT-CYB MT-CO1 LINC01554
33 norwegian scabies 10.1
34 theileriasis 10.1 MT-CYB MT-CO1
35 taeniasis 10.1 MT-CYB MT-CO1
36 babesiosis 10.1 MT-CYB MT-CO1
37 gastric antral vascular ectasia 10.0
38 diffuse idiopathic skeletal hyperostosis 10.0
39 keratitis, hereditary 10.0
40 vitiligo-associated multiple autoimmune disease susceptibility 6 10.0
41 congenital hemidysplasia with ichthyosiform erythroderma and limb defects 10.0
42 vitiligo-associated multiple autoimmune disease susceptibility 1 10.0
43 epidemic typhus 10.0
44 relapsing fever 10.0
45 excessive tearing 10.0
46 urticaria 10.0
47 dermatitis 10.0
48 skin disease 10.0
49 conjunctivitis 10.0
50 seborrheic dermatitis 10.0

Graphical network of the top 20 diseases related to Lice Infestation:



Diseases related to Lice Infestation

Symptoms & Phenotypes for Lice Infestation

Drugs & Therapeutics for Lice Infestation

Drugs for Lice Infestation (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 37)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Pharmaceutical Solutions Phase 4
2
Ethanol Approved Phase 3 64-17-5 702
3
Benzyl alcohol Approved Phase 3 100-51-6 244
4
Ivermectin Approved, Investigational, Vet_approved Phase 3 70288-86-7 9812710 6427057
5
Malathion Approved, Investigational Phase 3 121-75-5 4004
6
Permethrin Approved, Investigational Phase 3 52645-53-1 40326
7 Rue Phase 3
8 Anesthetics, Local Phase 3
9 Anesthetics Phase 3
10 Anti-Infective Agents Phase 3
11 Antiparasitic Agents Phase 3
12 Neurotransmitter Agents Phase 3
13 Cholinesterase Inhibitors Phase 3
14 Cholinergic Agents Phase 3
15 Anti-Infective Agents, Local Phase 3
16 Pulmonary Surfactants Phase 3
17 Neem Phase 2
18
Estradiol Approved, Investigational, Vet_approved Phase 1 50-28-2 5757
19
Ethinylestradiol Approved Phase 1 57-63-6 5991
20
Polyestradiol phosphate Approved Phase 1 28014-46-2
21
Norgestimate Approved, Investigational Phase 1 35189-28-7 6540478
22
Moxifloxacin Approved, Investigational Phase 1 186826-86-8, 354812-41-2, 151096-09-2 152946
23 Anti-Bacterial Agents Phase 1
24 Estradiol 3-benzoate Phase 1
25 Estradiol 17 beta-cypionate Phase 1
26 Contraceptives, Oral, Combined Phase 1
27 Contraceptives, Oral Phase 1
28 Contraceptive Agents Phase 1
29 Norgestimate, ethinyl estradiol drug combination Phase 1
30
Azithromycin Approved 83905-01-5 447043
31
Albendazole Approved, Vet_approved 54965-21-8 2082
32 Antimitotic Agents
33 Antiprotozoal Agents
34 Anthelmintics
35 Tubulin Modulators
36 Bee Products
37 Propolis

Interventional clinical trials:

(show top 50) (show all 55)
# Name Status NCT ID Phase Drugs
1 A Single Treatment, Pharmacokinetic (PK) and Tolerance Study of Natroba (Spinosad) Topical Suspension, 0.9% in Pediatric Subjects 6 Months to 4 Years of Age With an Active Head Lice Infestation Completed NCT01660321 Phase 4 spinosad
2 A Randomised, Assessor Blind, Parallel Group, Comparative Trial of the Ovicidal Activity of Three Head Lice Products (NeutraLice Lotion®, NeutraLice Advance® and Moov Head Lice Solution®) After a Single Application Completed NCT00995124 Phase 4 NeutraLice Lotion;NeutraLice Advance Solution;Moov Head Lice Solution
3 Phase 3 Efficacy and Safety Study for PIOLIN® Shampoo to Treat Pediculosis Unknown status NCT01966965 Phase 3 PIOLIN®;NEDAX
4 A Randomized, Double-blind, Multicenter, Vehicle-controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation Completed NCT02062060 Phase 3 Abametapir Lotion 0.74% w/w;Vehicle Lotion
5 A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation Completed NCT02060903 Phase 3 Abametapir Lotion 0.74% w/w;Vehicle Lotion
6 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of Ivermectin Lotion 0.5% (Actavis Laboratories UT, Inc.) to SKLICE® (Ivermectin) Lotion, 0.5% (Arbor Pharmaceuticals, LLC) in the Treatment of Human Head Lice Infestation Completed NCT03301649 Phase 3 Generic Ivermectin Lotion 0.5%;Sklice® (Ivermectin) Lotion 0.5%;Vehicle Lotion
7 A Randomised, Double-Blind, Multicentre Study to Compare the Efficacy and Tolerability of Oral Ivermectin to Malathion 0.5% Lotion in the Treatment of Head Lice Infestation Completed NCT00819520 Phase 3 ivermectin;malathion
8 A Phase 3 Comparative Safety and Efficacy Study Between NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects >6 Months of Age or Older With Pediculosis Capitis Completed NCT00545753 Phase 3 Spinosad;Permethrin 1%
9 Phase II, Multi-Center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis Completed NCT00752973 Phase 2, Phase 3 MALG (malathion) Treatment
10 A Phase 3 Comparative Safety and Efficacy Study Between NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects > 6 Months of Age With Pediculosis Capitis Completed NCT00545168 Phase 3 Spinosad;Permethrin 1%
11 A Multi-Center Phase III Study to Evaluate MALG, a Novel Malathion 0.05%Formulation, for the Control of Head Lice in Pediatric and Adult Subjects With Pediculosis Capitis Completed NCT00244439 Phase 3 MALG;Ovide (malathion) lotion 0.05%;Permethrin 1%
12 A Multi-Center Phase III Study to Evaluate Malathion Gel 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis Completed NCT00963508 Phase 3 Malathion gel 0.5%;Permethrin 1% rinse (Nix Crème)
13 A Multi-Center Phase III Study to Evaluate Ovide Lotion 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis Completed NCT00927472 Phase 3 Malathion gel 0.5%;Permethrin 1% rinse
14 A Randomised, Controlled and Blinded Assessment Study of the Efficacy of MOOV Head Lice Treatment (Ego Pharmaceutical Pty. Ltd.) in the Treatment of Head Lice in Primary School Children. Completed NCT00381082 Phase 2, Phase 3 1) MOOV Head Lice Treatment (Ego Pharmaceutical).;Banlice Mousse Aerosol (Pfizer, Australia);3) KP24 Medicated Foam (Nelson Laboratories)
15 A Multi-Center, Randomized, Vehicle Controlled, Double Blind Clinical Trial to Evaluate the Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.) for the Treatment of Head Lice. Completed NCT00479310 Phase 3 Summers 5% L.A.
16 A Randomized, Multi-Center, Double-blind, Placebo Controlled, Parallel Group Trial to Evaluate Efficacy and Safety of Mayne Pharma's Ivermectin 0.5% Lotion Compared to Sklice® Ivermectin 0.5% Lotion in the Treatment of Head Lice Completed NCT03337490 Phase 3 Ivermectin 0.5% Topical Application Lotion;Ivermectin 0.5% Topical Application Lotion [SKLICE];Placebo 0% Lotion
17 Bioequivalence Study for Benzyl Alcohol Lotion 5% (Hi-Tech Pharmacal Co. LTD) and Ulesfia (Benzyl Alcohol Lotion 5%) (Shionogi Inc.) in the Treatment of Head Lice and Their Ova. Completed NCT02624843 Phase 3 Benzyl Alcohol Lotion 5%;Ulesfia (benzyl alcohol lotion) 5%;Placebo
18 An Open Trial to Evaluate the Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.) for the Treatment of Head Lice Completed NCT00301340 Phase 3 5% Lice Asphyxiator lotion - Summers Laboratories, Inc.
19 A Multi-Center, Randomized, Vehicle Controlled, Double Blind Clinical Trial to Evaluate the Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.) for the Treatment of Head Lice. Completed NCT00301327 Phase 3 Summers 5% L.A.
20 A Double-Blind Randomized Study to Compare the Efficacy, Safety and Local Tolerability of a 0.5% Ivermectin Cream Compared to a Topical Vehicle Control in Subjects With Pediculus Humanus Capitis Infestation Completed NCT01066585 Phase 3 Ivermectin Cream;vehicle control
21 Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands Completed NCT03236168 Phase 3 Ivermectin;Permethrin 5%;Malathion Shampoo 0.5%
22 A Randomised, Controlled, Assessor-blind, Parallel Group Clinical Trial to Assess the Efficacy, Safety and Acceptability of a Surfactant Based Lotion and a Permethrin Creme Rinse in the Treatment of Head Lice Terminated NCT02500524 Phase 3 Cocamide diethanolamine;Permethrin
23 A Randomised, Parallel Group Clinical Trial to Assess the Efficacy, Safety and Acceptability of a Surfactant Based Lotion in the Treatment of Head Louse Infection. Terminated NCT02499549 Phase 2, Phase 3 cocamide diethanolamine
24 A Pediatric Safety and Pharmacokinetic Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation Completed NCT02010333 Phase 2 Ha44 Gel 0.74% w/w
25 A Safety and Pharmacokinetic Study of Ha44 Gel Administered Topically Under Maximal Use Conditions for the Treatment of Head Lice Infestation. Completed NCT01907490 Phase 2 Ha44 Gel
26 A Randomised, Double-Blind, Vehicle-Controlled Study of Ovicidal Efficacy and Safety of Abametapir 0.74% Administered for the Treatment of Head Lice Infestation Completed NCT02097485 Phase 2 Abametapir Lotion 0.74% w/w;Vehicle Lotion
27 A Randomized, Double-Blind, Placebo-Controlled Clinical Trial On The Efficacy And Safety Of Topical 0.5% Ivermectin Lotion For The Treatment Of Head Lice Infestation Among Filipino Children Age 3 Years Or Older Completed NCT03286101 Phase 2 0.5% Ivermectin lotion;Vehicle
28 A Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of 3 Strengths of Ivermectin Treatment Conditioner and Placebo in Subjects With Pediculus Humanus Capitis (Head Lice) Infestation Completed NCT00857948 Phase 2 ivermectin treatment conditioner;Placebo, vehicle control
29 A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation Completed NCT00528021 Phase 2 Placebo;BGC20-0582
30 An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation Completed NCT01336647 Phase 2 Group A - Low-Dose Ha44 0.37% w/w;Group B - High Dose Ha44 Gel 0.74% w/w;Group C - Placebo
31 Efficacy and Safety of Different Strengths of Spinosad Topical Creme (0%, 0.5%, 1.0% or 2%) in Subjects With Pediculosis Capitis - a Dose Ranging Study Completed NCT00858481 Phase 2 Spinosad Creme Rinse - Vehicle Control;Spinosad Creme Rinse
32 A Pilot Study to Test the Operational Elements of an Actual Use Study Designed to Compare the Safety and Efficacy of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months of Age or Older With Pediculosis Capitis Completed NCT00857935 Phase 2 NatrOVA Creme Rinse - 1%;NIX Creme Rinse - 1% permethrin
33 Phase 2 Study of Efficacy and Safety of Different Strengths of Spinosad Topical Creme Rinse (0%, 0.5% or 1.0%) in Subjects 2 Years of Age or Older With Pediculosis Capitis - A Dose Ranging Study Completed NCT00311779 Phase 2 Spinosad Creme Rinse
34 A Randomised, Assessor Blinded "Proof of Concept" (Phase IIa) Clinical Study to Assess the Efficacy and Safety of Nice 'n Clear Head Lice Lotion in the Treatment of Head Lice Completed NCT02974088 Phase 2
35 Safety and Efficacy of a 100% Dimethicone Pediculocide in School-Age Children Completed NCT02213055 Phase 2 LICEMD;Standard Head lice product
36 Phase II, Multi-center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis Terminated NCT00291057 Phase 2 MALG
37 An Open-label Study to Assess the Bioavailability, Safety, Local Tolerance, and Efficacy of 0.5% Ivermectin Cream in Subjects 6 Months to 3 Years of Age With Pediculus Humanus Capitis (Head Lice) Infestation Completed NCT00988533 Phase 1 0.5% Ivermectin Cream
38 A Randomized, Single-Dose, Parallel Group, Comparative Pharmacokinetic (PK) Study to Evaluate Malathion Gel 0.5% Versus Ovide (Malathion) Lotion 0.5% in Patients With Pediculosis Capitis Completed NCT00927407 Phase 1 Malathion gel 0.5%;Malathion lotion 0.5%
39 A Phase 1B Single Treatment, Pharmacokinetic and Tolerance Study of NatroVA Topical Creme (1%) i Pediatric Subjects 6 to 24 Months of Age Completed NCT00410709 Phase 1 NatrOVA Creme Rinse (1%)
40 A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Effect of Ha44 Gel on the ECG in Healthy Adult Subjects Completed NCT01518699 Phase 1 Ha44;Ha44 Placebo;Moxifloxacin Placebo;Moxifloxacin
41 A Multi-Center, Double-Blind, Randomized, Placebo Controlled, Parallel-group Study, Comparing Ivermectin Lotion, 0.5% in the Treatment of Subjects With Active Infestation With Head Lice and Their Ova Completed NCT03257943 Phase 1 Ivermectin Lotion, 0.5%;SKLICE (ivermectin) Lotion, 0.5%;Vehicle of the Test product
42 Clinical Trial of Anti-Lice Treatment Using the Medical Device "No More" Which is Designed to Kill Lice and Lice Eggs on the Head. Unknown status NCT02569580
43 Treatment of Head Lice Infestation Using Novel Ultrasonic Comb Completed NCT02854878
44 Scalp Pruritus Measurement Using Visual Analog Scale and 5-d Itch Scale in Children With Pediculosis Capitis Completed NCT04415034
45 Study of the Therapeutic Efficacy of the Combination Azithromycin + Ivermectin in the Treatment of Pediculosis in Senegal (IVERAZITH) Completed NCT03578679 Ivermectin Oral Product
46 Control of Head Lice in Children and Adults Completed NCT00731718
47 Efficacy and Nutritional Assessment Following Albendazole and Combined Albendazole/Ivermectin Treatment for Intestinal Helminth Infections in Rural Guatemalan Schoolchildren Completed NCT00207753 albendazole vs. combined albendazole/ivermectin treatment
48 A Randomized, Controlled, Investigator-Assessor Blinded, Comparative Study to Evaluate the Safety and Efficacy of a Water-Soluble Head Lice Suffocation Product (X92001666) vs RID Shampoo (Pyrethrin) in Subjects With Head Lice Completed NCT03617926
49 A Comparative Study to Demonstrate the Efficacy and Safety of Licefreee Spray Against Nix 1% Permethrin in Head Lice Infested Individuals Completed NCT01514513 Licefreee Spray;1% permethrin creme rinse
50 An Open Label Randomized Study to Compare the Safety and Efficacy of Silcap Plus (Approximately 4% Dimeticone) Against Nix Cream Rinse. Completed NCT00672971

Search NIH Clinical Center for Lice Infestation

Inferred drug relations via UMLS 71 / NDF-RT 50 :


ANISE OIL/CORIANDER OIL/LEMON OIL/ORANGE OIL
Benzyl Alcohol
Ivermectin
Lindane
Malathion
Pediculicide [EPC]
Permethrin
Piperonyl Butoxide
spinosad

Cochrane evidence based reviews: lice infestations

Genetic Tests for Lice Infestation

Anatomical Context for Lice Infestation

Organs/tissues related to Lice Infestation:

MalaCards : Skin, Eye, Liver

Publications for Lice Infestation

Articles related to Lice Infestation:

(show top 50) (show all 1216)
# Title Authors PMID Year
1
Staying Ahead of Head Lice: Pediculosis Treatment Updates. 62
35549543 2022
2
Dual RNA-Seq Analysis Reveals Transcriptome Effects during the Salmon-Louse Interaction in Fish Immunized with Three Lice Vaccines. 62
36366383 2022
3
Prevalence of Pediculosis Among Primary School-Aged Students in Iran: an Updated Comprehensive Systematic Review and Meta-Analysis. 62
36166587 2022
4
Isoxazolines for treating canine demodicosis, sarcoptic mange (scabies), and lice infestation. 62
36325416 2022
5
Safety and Efficacy of Pure and a Nanosuspension of D-limonene for Controlling Pigeon Lice. 62
36398898 2022
6
Effect of Education and Regular Examination on the Prevalence of Head Louse Infestations in Adana 62
36444409 2022
7
The nit sheath: A rare histopathologic clue for the diagnosis of louse infestation. 62
35923069 2022
8
Head Lice. 62
36156158 2022
9
Pediculid: Literature Review with Case Presentation. 62
36161081 2022
10
Over-the-counter Pediculus humanus capitis treatment: The nit comb is not appropriate for all hair types! 62
36241488 2022
11
Prevalence of Pediculus humanus capitis and associated risk factors among elementary school-aged girls in Paveh, West Iran. 62
36223628 2022
12
Hypotension Unresponsive to Fluid Resuscitation: A Case Report. 62
36049191 2022
13
Molecular and functional characterization of GABA receptor subunits GRD and LCCH3 from human body louse Pediculus humanus humanus. 62
35853710 2022
14
A Rare Case of Anemia Secondary to Lice Infestation. 62
35989849 2022
15
Abametapir 0.74% (Xeglyze) for the Treatment of Head Lice. 62
35839355 2022
16
Impact of a health educational interventional program on reducing the head lice infestation among pupils in an elementary school of a sub-tropical region: a quasi-experimental study. 62
35850860 2022
17
Pubic Pediculosis. 62
35895349 2022
18
The Attractivity of the Head Louse, Pediculus humanus capitis (Pediculidae: Anoplura) to Isolated Compounds and Blends of Human Skin. 62
35482601 2022
19
Temperature affects settlement success of ectoparasitic salmon lice (Lepeophtheirus salmonis) and impacts the immune and stress response of Atlantic salmon (Salmo salar). 62
35397139 2022
20
'Tree of lice' pinpoints first mammal with a louse infestation. 62
35788717 2022
21
Exploring Sea Lice Vaccines against Early Stages of Infestation in Atlantic Salmon (Salmo salar). 62
35891227 2022
22
"Doctor, You Must Examine My Creature Collection!": A Case Report of Delusional Infestation. 62
35812529 2022
23
Association of Body Lice Infestation With Hemoglobin Values in Hospitalized Dermatology Patients. 62
35442410 2022
24
Bacteriologic Profile Along With Antimicrobial Susceptibility Pattern of Pediatric Pyoderma in Eastern India. 62
35812626 2022
25
Head Lice Infestation: An Unusual Cause of Iron Deficiency Anemia in a 13-Year-Old Female. 62
35855249 2022
26
Skin disease in goats (Capra aegagrus hircus): a retrospective study of 358 cases at a university veterinary teaching hospital (1988-2020). 62
34961979 2022
27
Human pediculosis, a global public health problem. 62
35619191 2022
28
Time series covering up to four decades reveals major changes and drivers of marine growth and proportion of repeat spawners in an Atlantic salmon population. 62
35386868 2022
29
A 12-Year-old Girl With Chronic Pediculosis Infestation Presenting With Severe Iron Deficiency Anemia. 62
34486551 2022
30
The Italian Mandatory Notification System: An Important Public Health Tool For Continuous Monitoring Of Infectious Diseases. 62
35699560 2022
31
Entodermoscopy of Pediculosis capitis. 62
35330983 2022
32
Effectiveness of Topical 0.5% Ivermectin Shampoo in the Treatment of Pediculosis Capitis among School-going Female Children. 62
35531485 2022
33
Variation in volatile organic compounds in Atlantic salmon mucus is associated with resistance to salmon lice infection. 62
35318390 2022
34
Prevalence of Pediculus humunus capitis, Pediculus humanus corporis, and Pthirus pubis in Al-Kut, Iraq. 62
35891768 2022
35
Heavy head lice infestation in an adolescent girl following benzodiazepine poisoning. 62
35140946 2022
36
Pediculosis Is a Risk Factor for Iron Deficiency Anaemia. 62
35371818 2022
37
Veratrum Alkaloid Determination in Four Cases of Veratrum Aqua Poisonings. 62
33559680 2022
38
The darker side of head lice infestations. 62
35190069 2022
39
Characteristics of homeless persons hospitalized in health care facilities in the Czech Republic in 2006-2015. 62
35477267 2022
40
Pediculosis knowledge among schoolchildren parents and its relation with head lice prevalence. 62
35730862 2022
41
Explaining the Determinants of Pediculosis Control and Prevention: A Qualitative Study in Southern Iran. 62
35363562 2022
42
Paediatrics: how to manage pediculosis capitis. 62
35371269 2022
43
Head Lice Infestation in Schoolchildren, in Poland-Is There a Chance for Change? 62
35160233 2022
44
Knowledge, Attitudes, Psychosocial Perspectives and Applied Epidemiology in the Control of Head Lice (pediculosis capitis) in Croatian Preschool Children: A Qualitative Study on Childcare Professionals and Health Coordinators. 62
35053689 2022
45
Evaluation of Anti-lice Topical Lotion of Ozonated Olive Oil and Comparison of its Effect with Permethrin Shampoo. 62
34856913 2022
46
Epidemiological and therapeutic studies on sheep lice in Sayint district, South Wollo Zone, Northeast Ethiopia. 62
36406066 2022
47
Prevalence of sheep lice and trends in control practices across Australia - Australian sheep parasite control surveys from 2003 to 2019. 62
35012719 2022
48
Investigation on prevalence, risk factors, and genetic diversity of Pediculus humanus capitis among primary school children. 62
35809265 2022
49
Protective Immunization of Atlantic Salmon (Salmo salar L.) against Salmon Lice (Lepeophtheirus salmonis) Infestation. 62
35062677 2021
50
Molecular survey of head lice (Pediculus humanus capitis) infestation among disadvantaged children in Klang Valley, Malaysia. 62
35001925 2021

Variations for Lice Infestation

Expression for Lice Infestation

Search GEO for disease gene expression data for Lice Infestation.

Pathways for Lice Infestation

GO Terms for Lice Infestation

Cellular components related to Lice Infestation according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 obsolete integral component of mitochondrial inner membrane GO:0031305 8.96 MT-CYB COX18
2 mitochondrial respiratory chain complex III GO:0005750 8.92 MT-CYB MT-CO1

Biological processes related to Lice Infestation according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 respiratory electron transport chain GO:0022904 8.8 MT-CYB MT-CO1

Sources for Lice Infestation

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....